Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine, and Biogen Inc. (Nasdaq: BIIB), today ...

Steven Gerrard has been told he would be a “good fit” and “attract some big-name players” to Wrexham if Phil Parkinson comes ...

Here’s how to watch the EFL Cup on TV and live stream. The Sporting News takes you through all the information you need to follow the game.

Wrexham forward Ryan Hardie says he apologised to his team-mates for missing a "crucial" chance at Southampton that might ...

If you don’t like getting soaked in the rains but still can’t stay away from travelling, consider visiting Ladakh to escape rains ...

Global, pivotal Phase 3 study will evaluate efficacy and safety of zorevunersen compared to sham over a 52-week treatment ...

Analysts have given Stoke Therapeutics a total of 3 ratings, with the consensus rating being Buy. The average one-year price target is $29.0, indicating a potential 121.37% upside.

Venture Global VG is estimated to report quarterly earnings at $0.20 per share on revenue of $2.95 billion. • ChipMOS TECHNOLOGIES IMOS is projected to report earnings for i ...

Stumptown reigns supreme in the cold brew world, setting the gold standard that other brands aspire to match. Their ...

Wrexham lost 2-1 at St. Mary's to the recently relegated Saints, with two late goals from Ryan Manning and Jack Stephens ...

Phil Parkinson remains determined to further bolster his Wrexham squad but insists players already at the club will be given ...

Conor Coady says Wrexham want to "upset and disrupt" Championship teams this season, despite their gut-wrenching loss at ...